MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
American Heart Journal
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,105 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,105 works in the cohort · of 4,299,418page 6 of 23

Labels cover 0 of 1,105 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,105 of 1,105 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study
Akshay Bagai, Paul W. Armstrong, Amanda Stebbins, Kenneth W. Mahaffey, Judith S. Hochman, W. Douglas Weaver +3 more
2013· article· en· American Heart Journal· Medicine
distilled prediction:candidate · noneconsensus · none
71
citations
affno abstractunlabeled
Outcome of patients aged ≥75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: Do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?
Vladimír Džavík, Lynn A. Sleeper, Michael H. Picard, Timothy A. Sanborn, April M. Lowe, Ken Gin +5 more
2005· article· en· American Heart Journal· Engineering
distilled prediction:candidate · metaepi_narrowconsensus · none
70
citations
affno abstractunlabeled
Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial
Adam B. Greenbaum, E. Magnus Ohman, C. Michael Gibson, Steven Borzak, Amanda Stebbins, Mei Lü +4 more
2007· article· en· American Heart Journal· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
66
citations
affunlabeled
Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials
Paul M. Ridker, Pierre Amarenco, Robert Brunell, Robert J. Glynn, J. Wouter Jukema, John J.P. Kastelein +7 more
2016· article· en· American Heart Journal· Medicine
distilled prediction:candidate · noneconsensus · none
64
citations
← previousnext →

How this was built: Screen · Findings · About